Clinical Trial Update: Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating once-weekly oral aripiprazole for Tourette's disorder in children and adolescents has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Tourette's Disorder | Phase 3 | Status: COMPLETED | Results posted: 2021-10-07